Medicare Enrolled

Dr. Wally Plante, MD

Neurology · Bonita Springs, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
28420 BONITA XING BLVD UNIT 110, Bonita Springs, FL 34135
2392350385
In practice since 2014 (11 years)
NPI: 1558772061 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Plante from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Plante? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Plante

Dr. Wally Plante is a neurology in Bonita Springs, FL, with 11 years in practice. Based on federal Medicare data, Dr. Plante performed 69,956 Medicare services across 790 unique beneficiaries.

Between the years covered by Open Payments, Dr. Plante received a total of $18,427 from 59 pharmaceutical and/or device companies across 557 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Plante is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice▲ Top 1% volume in FL$ $18,427 industry payments

Medicare Practice Summary

Medicare Utilization ↗
69,956
Medicare services
Top 1% in FL for neurology
790
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,360 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Injection, lecanemab-irmb, 1 mg58,885$1$3
Inclisiran injection (Leqvio) for cholesterol9,940$9$27
Administration of chemotherapy into vein, 1 hour or less298$107$369
Office visit, established patient, complex (40-54 min)216$140$524
Office visit, established patient (30-39 min)162$95$375
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes105$201$617
New patient office visit, complex (60-74 min)82$168$643
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less48$53$181
Evaluation of neuropsychological test, first hour46$104$297
Administration of psychological or neuropsychological test by technician, first 30 minutes46$27$77
Measurement of brain wave activity (eeg), awake and drowsy40$305$847
Drug injection, under skin or into muscle37$12$41
New patient office visit (45-59 min)24$130$484
Administration of chemotherapy into vein, each additional hour16$23$82
Office visit, established patient (20-29 min)11$73$274
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
98.9% medium
1.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$18,427
Total received (2018-2024)
Avg $2,632/year across 7 years
Top 17% in FL for neurology
59
Companies
557
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,885 (75.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,433 (24.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$110 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,939
2023
$3,620
2022
$2,396
2021
$1,008
2020
$3,605
2019
$3,649
2018
$209

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Biogen, Inc.
$4,182
LivaNova USA, Inc.
$1,671
OnMark, Inc.
$1,400
Lilly USA, LLC
$1,130
UCB, Inc.
$898
ABBVIE INC.
$771
Alnylam Pharmaceuticals Inc.
$505
Amgen Inc.
$474
GE HealthCare
$431
GENZYME CORPORATION
$425
Eisai Inc.
$422
GE HEALTHCARE
$397
Teva Pharmaceuticals USA, Inc.
$382
ARGENX US, INC.
$379
Genentech USA, Inc.
$365
EMD Serono, Inc.
$334
Novartis Pharmaceuticals Corporation
$305
AbbVie Inc.
$289
Neurocrine Biosciences, Inc.
$273
Corium, LLC
$241
Acorda Therapeutics, Inc
$234
Supernus Pharmaceuticals, Inc.
$224
Janssen Pharmaceuticals, Inc
$214
Neurelis, Inc.
$209
Alexion Pharmaceuticals, Inc.
$149
E.R. Squibb & Sons, L.L.C.
$144
Celgene Corporation
$132
ACADIA Pharmaceuticals Inc
$130
Biohaven Pharmaceuticals, Inc.
$128
Lundbeck LLC
$128
Allergan Inc.
$127
PFIZER INC.
$120
Otsuka America Pharmaceutical, Inc.
$119
Nevro Corp.
$98
MDD US Operations, LLC
$89
Life Molecular Imaging Ltd
$88
Sunovion Pharmaceuticals Inc.
$77
Shire North American Group Inc
$66
Allergan, Inc.
$65
Boston Scientific Corporation
$60
IDORSIA PHARMACEUTICALS US INC
$56
Merz Pharmaceuticals, LLC
$53
GRT US Holding, Inc.
$43
Avanir Pharmaceuticals, Inc.
$43
EISAI INC.
$41
Amneal Pharmaceuticals LLC
$35
Takeda Pharmaceuticals U.S.A., Inc.
$35
Amarin Pharma Inc.
$33
Mallinckrodt Hospital Products Inc.
$25
Merck Sharp & Dohme Corporation
$25
Ipsen Biopharmaceuticals, Inc
$24
TG THERAPEUTICS, INC.
$24
Mallinckrodt LLC
$21
SANOFI-AVENTIS U.S. LLC
$19
Avion Pharmaceuticals
$19
La Jolla Pharmaceutical Company
$16
Bayer HealthCare Pharmaceuticals Inc.
$16
MITSUBISHI TANABE PHARMA AMERICA, INC.
$13
Actelion Pharmaceuticals US, Inc.
$12
Top 3 companies account for 39.4% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMYVID · AUBAGIO · AUSTEDO · AVONEX · Adempas · Adlarity · Aduhelm · Aimovig · Austedo XR · BOTOX · BRIUMVI · Briviact · CHANTIX · DYSPORT · Dhivy · EMGALITY · EVENITY · GIAPREZA · GILENYA · GOCOVRI · INBRIJA · INGREZZA · KISUNLA · KYNMOBI · LEMTRADA · LEQVIO · Leqembi · MAVENCLAD · Mavenclad · NEURACEQ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nuedexta · OCREVUS · ONPATTRO · OPSUMIT MACITENTAN · OXTELLAR XR · Ocrevus · Omnia · Ongentys · Ponvory · Prolia · QULIPTA · QUVIVIQ · Qutenza · RADICAVA · REXULTI · ROTATEQ · RYTARY · Rystiggo · SOLIRIS · SPRAVATO · Senza · Soliris · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vascepa · Vimpat · WATCHMAN Access System · Xeomin · ZEPOSIA · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (75%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $26 per 100 Medicare services performed
Looking for a neurology in Bonita Springs?
Compare neurologys in the Bonita Springs area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
195
Per 100K population
24.6
County median income
$73,099
Nearest hospital
PHYSICIANS REGIONAL MEDICAL CENTER - PINE RIDGE
7.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Plante is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (low-engagement, top 17%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Plante experienced with injection, lecanemab-irmb, 1 mg?
Based on Medicare claims data, Dr. Plante performed 58,885 injection, lecanemab-irmb, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Plante receive payments from pharmaceutical companies?
Yes. Dr. Plante received a total of $18,427 from 59 companies across 557 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Plante's costs compare to other neurologys in Bonita Springs?
Dr. Plante's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Plante) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →